Related Experiment Video
Updated: Aug 5, 2026

08:03
Treatment of Ligament Constructs with Exercise-conditioned Serum: A Translational Tissue Engineering Model
Published on: June 11, 2017
Liquid chromatographic determination of hydroxyproline in tissue samples
Paul R Hutson1, Mark E Crawford, Ronald L Sorkness
1UW School of Pharmacy, 777 Highland Avenue, Madison, WI 53705-2222 USA. prhutson@pharmacy.wisc.edu
Summary
A new assay accurately measures hydroxyproline in rat lungs, crucial for studying collagen and fibrosis. This method is highly precise, with variability under 1%.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Pulmonary Medicine
Background:
- Hydroxyproline is a key component of collagen.
- Accurate measurement of hydroxyproline is essential for assessing collagen content and diagnosing fibrotic lung diseases.
- Existing assays may lack the sensitivity or precision required for small tissue samples.
Purpose of the Study:
- To develop and validate a sensitive reversed-phase assay for quantifying hydroxyproline in rat lung tissue.
- To establish a reliable method for measuring collagen-related changes in pulmonary fibrosis research.
Main Methods:
- A reversed-phase assay was developed for hydroxyproline quantification.
- Sarcosine was used as the internal standard.
- Pre-injection derivatization was performed using o-phthalaldehyde (OPA) and 9-fluorenylmethylchloroformate (FMOC).
Main Results:
- The assay demonstrated high precision, with intra-assay variability below 1% for hydroxyproline concentrations between 25-500 microM.
- Normal rat left lung hydroxyproline content was determined to be 1.08+/-0.18 mg/lung.
- The assay is capable of measuring minute amounts of hydroxyproline.
Conclusions:
- The described reversed-phase assay provides a precise and sensitive method for hydroxyproline measurement in lung tissue.
- This assay is suitable for quantifying collagen and investigating pathological fibrosis in pulmonary research.
- The method's ability to detect small hydroxyproline quantities aids in early disease detection and monitoring.

